A detailed history of Rhumbline Advisers transactions in Dexcom Inc stock. As of the latest transaction made, Rhumbline Advisers holds 805,663 shares of DXCM stock, worth $64.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
805,663
Previous 805,357 0.04%
Holding current value
$64.6 Million
Previous $91.3 Million 40.87%
% of portfolio
0.05%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $19,584 - $35,514
306 Added 0.04%
805,663 $54 Million
Q2 2024

Aug 01, 2024

BUY
$110.31 - $140.45 $1.97 Million - $2.5 Million
17,817 Added 2.26%
805,357 $91.3 Million
Q1 2024

May 09, 2024

BUY
$114.22 - $140.1 $1.1 Million - $1.35 Million
9,661 Added 1.24%
787,540 $109 Million
Q4 2023

Feb 08, 2024

SELL
$75.49 - $124.16 $858,774 - $1.41 Million
-11,376 Reduced 1.44%
777,879 $96.5 Million
Q3 2023

Nov 09, 2023

BUY
$86.06 - $137.93 $11,445 - $18,344
133 Added 0.02%
789,255 $73.6 Million
Q2 2023

Aug 08, 2023

BUY
$112.47 - $130.98 $592,379 - $689,871
5,267 Added 0.67%
789,122 $101 Million
Q1 2023

May 11, 2023

BUY
$104.0 - $122.92 $4.94 Million - $5.83 Million
47,461 Added 6.45%
783,855 $91.1 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $1.34 Million - $1.94 Million
15,818 Added 2.2%
736,394 $83.4 Million
Q3 2022

Nov 10, 2022

BUY
$76.35 - $94.18 $920,933 - $1.14 Million
12,062 Added 1.7%
720,576 $58 Million
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $36.8 Million - $72 Million
541,883 Added 325.2%
708,514 $52.8 Million
Q1 2022

May 12, 2022

SELL
$94.08 - $130.2 $22,767 - $31,508
-242 Reduced 0.15%
166,631 $85.2 Million
Q4 2021

Feb 10, 2022

BUY
$129.87 - $162.82 $107,142 - $134,326
825 Added 0.5%
166,873 $89.6 Million
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $66,480 - $89,201
-623 Reduced 0.37%
166,048 $90.8 Million
Q2 2021

Aug 05, 2021

SELL
$80.99 - $107.93 $103,262 - $137,610
-1,275 Reduced 0.76%
166,671 $71.2 Million
Q1 2021

May 06, 2021

SELL
$84.79 - $104.74 $562,666 - $695,054
-6,636 Reduced 3.8%
167,946 $60.4 Million
Q4 2020

Feb 10, 2021

BUY
$78.0 - $104.5 $86,814 - $116,308
1,113 Added 0.64%
174,582 $64.5 Million
Q3 2020

Nov 12, 2020

BUY
$95.51 - $112.95 $240,398 - $284,295
2,517 Added 1.47%
173,469 $71.5 Million
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $4.73 Million - $7.95 Million
75,433 Added 78.97%
170,952 $69.3 Million
Q1 2020

May 06, 2020

SELL
$47.79 - $75.63 $81,099 - $128,344
-1,697 Reduced 1.75%
95,519 $25.7 Million
Q4 2019

Feb 05, 2020

BUY
$36.62 - $57.29 $75,144 - $117,559
2,052 Added 2.16%
97,216 $21.3 Million
Q3 2019

Oct 23, 2019

SELL
$35.53 - $43.8 $29,312 - $36,135
-825 Reduced 0.86%
95,164 $14.2 Million
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $100,418 - $140,384
-3,607 Reduced 3.62%
95,989 $14.4 Million
Q1 2019

May 01, 2019

SELL
$28.07 - $38.18 $44,238 - $60,171
-1,576 Reduced 1.56%
99,596 $11.9 Million
Q4 2018

Jan 31, 2019

SELL
$26.99 - $37.37 $5,074 - $7,025
-188 Reduced 0.19%
101,172 $12.1 Million
Q3 2018

Nov 07, 2018

BUY
$23.35 - $36.72 $4,436 - $6,976
190 Added 0.19%
101,360 $14.5 Million
Q2 2018

Aug 06, 2018

BUY
$17.54 - $25.22 $40,640 - $58,434
2,317 Added 2.34%
101,170 $9.61 Million
Q1 2018

May 02, 2018

SELL
$13.06 - $18.54 $37,978 - $53,914
-2,908 Reduced 2.86%
98,853 $7.33 Million
Q4 2017

Feb 09, 2018

SELL
$11.12 - $15.38 $20,772 - $28,729
-1,868 Reduced 1.8%
101,761 $5.84 Million
Q3 2017

Nov 06, 2017

BUY
$11.36 - $18.98 $1.18 Million - $1.97 Million
103,629
103,629 $5.07 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.